These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23012423)

  • 1. MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation.
    Romano G; Acunzo M; Garofalo M; Di Leva G; Cascione L; Zanca C; Bolon B; Condorelli G; Croce CM
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16570-5. PubMed ID: 23012423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BIM induction of apoptosis triggered by EGFR-sensitive and resistance cell lines of non-small-cell lung cancer.
    Li Z; Zhou S; Zhang L; Su C; Hang J; Zhao Y; Su B; Zhou C
    Med Oncol; 2011 Jun; 28(2):572-7. PubMed ID: 20237869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-92a mediates AZD6244 induced apoptosis and G1-phase arrest of lymphoma cells by targeting Bim.
    Lv XB; Zhang X; Deng L; Jiang L; Meng W; Lu Z; Wang X
    Cell Biol Int; 2014 Apr; 38(4):435-43. PubMed ID: 24375836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met.
    Sun C; Sang M; Li S; Sun X; Yang C; Xi Y; Wang L; Zhang F; Bi Y; Fu Y; Li D
    Oncotarget; 2015 Nov; 6(37):39756-92. PubMed ID: 26497851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ERK-BIM and STAT3-survivin signaling pathways in ALK inhibitor-induced apoptosis in EML4-ALK-positive lung cancer.
    Takezawa K; Okamoto I; Nishio K; Jänne PA; Nakagawa K
    Clin Cancer Res; 2011 Apr; 17(8):2140-8. PubMed ID: 21415216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway.
    Sun Y; Chen C; Zhang P; Xie H; Hou L; Hui Z; Xu Y; Du Q; Zhou X; Su B; Gao W
    Sci Rep; 2014 Oct; 4():6527. PubMed ID: 25284075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222.
    Acunzo M; Visone R; Romano G; Veronese A; Lovat F; Palmieri D; Bottoni A; Garofalo M; Gasparini P; Condorelli G; Chiariello M; Croce CM
    Oncogene; 2012 Feb; 31(5):634-42. PubMed ID: 21706050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
    Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells.
    Terasawa K; Ichimura A; Sato F; Shimizu K; Tsujimoto G
    FEBS J; 2009 Jun; 276(12):3269-76. PubMed ID: 19438724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.
    Wickenden JA; Jin H; Johnson M; Gillings AS; Newson C; Austin M; Chell SD; Balmanno K; Pritchard CA; Cook SJ
    Oncogene; 2008 Dec; 27(57):7150-61. PubMed ID: 18806830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic kit triggers Shp2/Erk1/2 pathway to down-regulate the pro-apoptotic protein Bim and to promote apoptosis resistance in leukemic cells.
    Selimoglu-Buet D; Gallais I; Denis N; Guillouf C; Moreau-Gachelin F
    PLoS One; 2012; 7(11):e49052. PubMed ID: 23145067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MiR-192 confers cisplatin resistance by targeting Bim in lung cancer].
    Zhang F; Li Y; Wu H; Qi K; You J; Li X; Zu L; Pan Z; Wang Y; Li Y; Li Y; Wang M; Shen W; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2014 May; 17(5):384-90. PubMed ID: 24854555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.
    Yang D; Wang JJ; Li JS; Xu QY
    Oncol Res; 2018 May; 26(4):519-528. PubMed ID: 28734041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-760 enhances TRAIL sensitivity in non-small cell lung cancer via targeting the protein FOXA1.
    Zhang X; Wang L; Liu Y; Huang W; Cheng D
    Biomed Pharmacother; 2018 Mar; 99():523-529. PubMed ID: 29665655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics.
    Cragg MS; Kuroda J; Puthalakath H; Huang DC; Strasser A
    PLoS Med; 2007 Oct; 4(10):1681-89; discussion 1690. PubMed ID: 17973573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
    Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
    Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT.
    Liu N; Zuo C; Wang X; Chen T; Yang D; Wang J; Zhu H
    Oncotarget; 2014 Jul; 5(13):4959-71. PubMed ID: 24970806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ebv-miR-BART7 on tumorigenicity, metastasis, and TRAIL sensitivity of non-small cell lung cancer.
    Wang L; Liu LF; Zhou L; Liao F; Wang J
    J Cell Biochem; 2019 Jun; 120(6):10057-10068. PubMed ID: 30569505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma.
    Kong LR; Chua KN; Sim WJ; Ng HC; Bi C; Ho J; Nga ME; Pang YH; Ong WR; Soo RA; Huynh H; Chng WJ; Thiery JP; Goh BC
    Mol Cancer Ther; 2015 Jul; 14(7):1750-60. PubMed ID: 25939760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.
    Sung B; Ravindran J; Prasad S; Pandey MK; Aggarwal BB
    J Biol Chem; 2010 Nov; 285(46):35418-27. PubMed ID: 20837473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.